Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events

go back to reference American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1):S62–7.PubMedCentralCrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1):S62–7.PubMedCentralCrossRef

go back to reference American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(1):S81–90.CrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(1):S81–90.CrossRef

go back to reference Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.PubMedCrossRef Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.PubMedCrossRef

go back to reference Ma H, Gao X, Lin HD, Hu Y, Li XM, Gao J, et al. Glycated haemoglobin in diagnosis of diabetes mellitus and pre-diabetes among middle-aged and elderly population: Shanghai Changfeng study. Biomed Environ Sci. 2013;26(3):155–62.PubMed Ma H, Gao X, Lin HD, Hu Y, Li XM, Gao J, et al. Glycated haemoglobin in diagnosis of diabetes mellitus and pre-diabetes among middle-aged and elderly population: Shanghai Changfeng study. Biomed Environ Sci. 2013;26(3):155–62.PubMed

go back to reference Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American diabetes association and the European association for the study of diabetes. In: Diabetes Care. 2006. p. 1963–1972. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American diabetes association and the European association for the study of diabetes. In: Diabetes Care. 2006. p. 1963–1972.

go back to reference Ketema EB, Kibret KT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health. 2015;73:43.PubMedPubMedCentralCrossRef Ketema EB, Kibret KT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health. 2015;73:43.PubMedPubMedCentralCrossRef

go back to reference Howard JA, Sommers R, Gould ON, Mancuso M. Effectiveness of an HbA1c tracking tool on primary care management of diabetes mellitus: glycaemic control, clinical practice and usability. Inform Prim Care. 2009;17(1):41–6.PubMed Howard JA, Sommers R, Gould ON, Mancuso M. Effectiveness of an HbA1c tracking tool on primary care management of diabetes mellitus: glycaemic control, clinical practice and usability. Inform Prim Care. 2009;17(1):41–6.PubMed

go back to reference Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95–104.PubMedPubMedCentralCrossRef Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95–104.PubMedPubMedCentralCrossRef

go back to reference Bennett CM, Guo M, Dharmage SC. HbA 1c as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med. 2007;24(4):333–43.PubMedCrossRef Bennett CM, Guo M, Dharmage SC. HbA _1c as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med. 2007;24(4):333–43.PubMedCrossRef

go back to reference Ang SH, Thevarajah M, Alias Y, Khor SM. Current aspects in hemoglobin A1c detection: a review. Clin Chim Acta. 2015;439:202–11.PubMedCrossRef Ang SH, Thevarajah M, Alias Y, Khor SM. Current aspects in hemoglobin A1c detection: a review. Clin Chim Acta. 2015;439:202–11.PubMedCrossRef

go back to reference Radin MS. Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med. 2014;29(2):388–94.PubMedCrossRef Radin MS. Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med. 2014;29(2):388–94.PubMedCrossRef

go back to reference Carr ME. Diabetes mellitus. J Diabetes Complicat. 2001;15(1):44–54.CrossRef Carr ME. Diabetes mellitus. J Diabetes Complicat. 2001;15(1):44–54.CrossRef

go back to reference Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2007;13(1):1–68. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2007;13(1):1–68.

go back to reference Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20(4):546–51.PubMedPubMedCentralCrossRef Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20(4):546–51.PubMedPubMedCentralCrossRef

go back to reference Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E. Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev. 2016;13(1):3–10.CrossRef Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E. Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev. 2016;13(1):3–10.CrossRef

go back to reference Stanton RC. Clinical challenges in diagnosis and management of diabetic kidney disease. Am J Kidney Dis. 2014;63(2):S3–21.PubMedCrossRef Stanton RC. Clinical challenges in diagnosis and management of diabetic kidney disease. Am J Kidney Dis. 2014;63(2):S3–21.PubMedCrossRef

go back to reference Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164–76.CrossRefPubMed Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164–76.CrossRefPubMed

go back to reference Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, et al. A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy. J Diabetes Investig. 2015;6(2):242–6.PubMedPubMedCentralCrossRef Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, et al. A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy. J Diabetes Investig. 2015;6(2):242–6.PubMedPubMedCentralCrossRef

go back to reference DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Prim. 2015;1. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Prim. 2015;1.

go back to reference Abedini A, Schmidt AM. Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett. 2013;587(8):1119–27.PubMedPubMedCentralCrossRef Abedini A, Schmidt AM. Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett. 2013;587(8):1119–27.PubMedPubMedCentralCrossRef

go back to reference Zhang X-X, Pan Y-H, Huang Y-M, Zhao H-L. Neuroendocrine hormone amylin in diabetes. World J Diabetes. 2016;7(9):189–97.PubMedPubMedCentralCrossRef Zhang X-X, Pan Y-H, Huang Y-M, Zhao H-L. Neuroendocrine hormone amylin in diabetes. World J Diabetes. 2016;7(9):189–97.PubMedPubMedCentralCrossRef

go back to reference Kohlgruber A, Lynch L. Adipose tissue inflammation in the pathogenesis of type 2 diabetes. Curr Diab Rep. 2015;15(11):92.PubMedCrossRef Kohlgruber A, Lynch L. Adipose tissue inflammation in the pathogenesis of type 2 diabetes. Curr Diab Rep. 2015;15(11):92.PubMedCrossRef

go back to reference Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CDA, Nijpels G, et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women the Hoorn study. Diabetes Care. 2006;29(11):2498–503.PubMedCrossRef Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CDA, Nijpels G, et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women the Hoorn study. Diabetes Care. 2006;29(11):2498–503.PubMedCrossRef

go back to reference Cox ME, Edelman D. Tests for screening and diagnosis of type 2 diabetes. Clin Diabetes. 2009;27(4):132–8.CrossRef Cox ME, Edelman D. Tests for screening and diagnosis of type 2 diabetes. Clin Diabetes. 2009;27(4):132–8.CrossRef

go back to reference Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15(7):815–9.PubMedCrossRef Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15(7):815–9.PubMedCrossRef

go back to reference Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr. 2017;9(1):25.PubMedPubMedCentralCrossRef Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr. 2017;9(1):25.PubMedPubMedCentralCrossRef

go back to reference Sharma S, Jackson PG, Makan J. Cardiac troponins. J Clin Pathol. 2004;57(10):1025–6.PubMedPubMedCentralCrossRef Sharma S, Jackson PG, Makan J. Cardiac troponins. J Clin Pathol. 2004;57(10):1025–6.PubMedPubMedCentralCrossRef

go back to reference Mythili S, Malathi N. Diagnostic markers of acute myocardial infarction. Biomed reports. 2015;3(6):743–8.CrossRef Mythili S, Malathi N. Diagnostic markers of acute myocardial infarction. Biomed reports. 2015;3(6):743–8.CrossRef

go back to reference Park KC, Gaze DC, Collinson PO, Marber MS. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res. 2017;113(14):1708–18.PubMedPubMedCentralCrossRef Park KC, Gaze DC, Collinson PO, Marber MS. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res. 2017;113(14):1708–18.PubMedPubMedCentralCrossRef

go back to reference Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006;92(7):987–93.PubMedPubMedCentralCrossRef Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006;92(7):987–93.PubMedPubMedCentralCrossRef

go back to reference Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PAW, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem. 1998;44(9):1919–24.PubMedCrossRef Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PAW, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem. 1998;44(9):1919–24.PubMedCrossRef

go back to reference Shave R, Dawson E, Whyte G, George K, Ball D, Collinson P, et al. The cardiospecificity of the third-generation cTnT assay after exercise-induced muscle damage. Med Sci Sports Exerc. 2002;34(4):651–4.PubMed Shave R, Dawson E, Whyte G, George K, Ball D, Collinson P, et al. The cardiospecificity of the third-generation cTnT assay after exercise-induced muscle damage. Med Sci Sports Exerc. 2002;34(4):651–4.PubMed

go back to reference Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 1995;41(12):1710–5.PubMedCrossRef Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 1995;41(12):1710–5.PubMedCrossRef

go back to reference Mair J, Lindahl B, Hammarsten O, Müller C, Giannitsis E, Huber K, et al. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018;7(6):553–60.PubMedCrossRef Mair J, Lindahl B, Hammarsten O, Müller C, Giannitsis E, Huber K, et al. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018;7(6):553–60.PubMedCrossRef

go back to reference Wu AHB. Cardiac markers: from enzymes to proteins, diagnosis to prognosis, laboratory to bedside. Ann Clin Lab Sci. 1999;29(1):18–23.PubMed Wu AHB. Cardiac markers: from enzymes to proteins, diagnosis to prognosis, laboratory to bedside. Ann Clin Lab Sci. 1999;29(1):18–23.PubMed

go back to reference Collinson PO, Gaze DC, Morris F, Morris B, Price A, Goodacre S. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria. Ann Clin Biochem. 2006;43(4):273–80.PubMedCrossRef Collinson PO, Gaze DC, Morris F, Morris B, Price A, Goodacre S. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria. Ann Clin Biochem. 2006;43(4):273–80.PubMedCrossRef

go back to reference Wu AHB, Valdes R, Apple FS, Gornet T, Stone MA, Mayfield-Stokes S, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem. 1994;40(6):900–7.PubMedCrossRef Wu AHB, Valdes R, Apple FS, Gornet T, Stone MA, Mayfield-Stokes S, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem. 1994;40(6):900–7.PubMedCrossRef

go back to reference Michielsen ECHJ, Diris JHC, Kleijnen VWVC, Wodzig WKWH, Van Dieijen-Visser MP. Investigation of release and degradation of cardiac troponin T in patients with acute myocardial infarction. Clin Biochem. 2007;40(12):851–5.PubMedCrossRef Michielsen ECHJ, Diris JHC, Kleijnen VWVC, Wodzig WKWH, Van Dieijen-Visser MP. Investigation of release and degradation of cardiac troponin T in patients with acute myocardial infarction. Clin Biochem. 2007;40(12):851–5.PubMedCrossRef

go back to reference Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction., Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J 2012; 33(20): 2551–2567. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction., Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J 2012; 33(20): 2551–2567.

go back to reference Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, ESC Scientific Document Group . 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016; 37(3): 267–315. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, ESC Scientific Document Group . 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016; 37(3): 267–315.

go back to reference Babuin L, Jaffe AS. Troponin: The biomarker of choice for the detection of cardiac injury. Vol. 173, CMAJ. 2005. p. 1191–202. Babuin L, Jaffe AS. Troponin: The biomarker of choice for the detection of cardiac injury. Vol. 173, CMAJ. 2005. p. 1191–202.

go back to reference Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vol. 7, Vascular Health and Risk Management. 2011. p. 597–603. Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vol. 7, Vascular Health and Risk Management. 2011. p. 597–603.

go back to reference Rubini Gimenez M, Twerenbold R, Reichlin T, Wildi K, Haaf P, Schaefer M, et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. Eur Heart J. 2014;35(34):2303–11.PubMedCrossRef Rubini Gimenez M, Twerenbold R, Reichlin T, Wildi K, Haaf P, Schaefer M, et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. Eur Heart J. 2014;35(34):2303–11.PubMedCrossRef

go back to reference Haaf P, Reichlin T, Twerenbold R, Hoeller R, Rubini Gimenez M, Zellweger C, et al. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J. 2014;35(6):365–75.PubMedCrossRef Haaf P, Reichlin T, Twerenbold R, Hoeller R, Rubini Gimenez M, Zellweger C, et al. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J. 2014;35(6):365–75.PubMedCrossRef

go back to reference Panteghini M. Standardization of cardiac troponin I measurements: The way forward? Vol. 51, Clinical Chemistry. 2005. p. 1594–1597.PubMedCrossRef Panteghini M. Standardization of cardiac troponin I measurements: The way forward? Vol. 51, Clinical Chemistry. 2005. p. 1594–1597.PubMedCrossRef

go back to reference Giuliani I, Bertinchant JP, Granier C, Laprade M, Chocron S, Toubin G, et al. Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia. Clin Chem. 1999;45(2):213–22.PubMedCrossRef Giuliani I, Bertinchant JP, Granier C, Laprade M, Chocron S, Toubin G, et al. Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia. Clin Chem. 1999;45(2):213–22.PubMedCrossRef

go back to reference Fahie-Wilson MN, Carmichael DJ, Delaney MP, Stevens PE, Hall EM, Lamb EJ. Cardiac troponin T circulates in the free, intact form in patients with kidney failure. Clin Chem. 2006;52(3):414–20.PubMedCrossRef Fahie-Wilson MN, Carmichael DJ, Delaney MP, Stevens PE, Hall EM, Lamb EJ. Cardiac troponin T circulates in the free, intact form in patients with kidney failure. Clin Chem. 2006;52(3):414–20.PubMedCrossRef

go back to reference Mair J. What is new on cardiac troponin degradation? J Lab Precis Med. 2017;2:55.CrossRef Mair J. What is new on cardiac troponin degradation? J Lab Precis Med. 2017;2:55.CrossRef

go back to reference Katrukha IA, Kogan AE, Vylegzhanina AV, Serebryakova MV, Koshkina EV, Bereznikova AV, et al. Thrombin-mediated degradation of human cardiac troponin T. Clin Chem. 2017;63(6):1094–100.PubMedCrossRef Katrukha IA, Kogan AE, Vylegzhanina AV, Serebryakova MV, Koshkina EV, Bereznikova AV, et al. Thrombin-mediated degradation of human cardiac troponin T. Clin Chem. 2017;63(6):1094–100.PubMedCrossRef

go back to reference Fridén V, Starnberg K, Muslimovic A, Ricksten S-E, Bjurman C, Forsgard N, et al. Clearance of cardiac troponin T with and without kidney function. Clin Biochem. 2017;50(9):468–74.PubMedCrossRef Fridén V, Starnberg K, Muslimovic A, Ricksten S-E, Bjurman C, Forsgard N, et al. Clearance of cardiac troponin T with and without kidney function. Clin Biochem. 2017;50(9):468–74.PubMedCrossRef

go back to reference Fu S, Jin R, Luo L, Ye P. Baseline type 2 diabetes had a significant association with elevated high sensitivity cardiac troponin T levels in Chinese community-dwelling population: a 5-year prospective analysis. Nutr Metab (Lond). 2017;14(1):73.CrossRef Fu S, Jin R, Luo L, Ye P. Baseline type 2 diabetes had a significant association with elevated high sensitivity cardiac troponin T levels in Chinese community-dwelling population: a 5-year prospective analysis. Nutr Metab (Lond). 2017;14(1):73.CrossRef

go back to reference Whelton SP, McEvoy JW, Lazo M, Coresh J, Ballantyne CM, Selvin E. High-sensitivity cardiac troponin T (hs-cTnT) as a predictor of incident diabetes in the atherosclerosis risk in communities study. Diabetes Care. 2017;40(2):261–9.PubMedCrossRef Whelton SP, McEvoy JW, Lazo M, Coresh J, Ballantyne CM, Selvin E. High-sensitivity cardiac troponin T (hs-cTnT) as a predictor of incident diabetes in the atherosclerosis risk in communities study. Diabetes Care. 2017;40(2):261–9.PubMedCrossRef

go back to reference Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc. 2009;84(10):917–38.PubMedPubMedCentralCrossRef Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc. 2009;84(10):917–38.PubMedPubMedCentralCrossRef

go back to reference Sanchis J, Bardají A, Bosch X, Loma-Osorio P, Marín F, Sánchez PL, et al. Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage. Am Heart J. 2012;164(2):194–200.PubMedCrossRef Sanchis J, Bardají A, Bosch X, Loma-Osorio P, Marín F, Sánchez PL, et al. Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage. Am Heart J. 2012;164(2):194–200.PubMedCrossRef

go back to reference Omland T, Pfeffer MA, Solomon SD, De Lemos JA, Røsjø H, Benth JŠ, et al. Prognostic value of cardiac troponin i measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61(12):1240–9.PubMedCrossRef Omland T, Pfeffer MA, Solomon SD, De Lemos JA, Røsjø H, Benth JŠ, et al. Prognostic value of cardiac troponin i measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61(12):1240–9.PubMedCrossRef

go back to reference Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, et al. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the global registry of acute coronary events. Arch Intern Med. 2009;169(4):402–9.PubMedCrossRef Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, et al. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the global registry of acute coronary events. Arch Intern Med. 2009;169(4):402–9.PubMedCrossRef

go back to reference Cavallini C, Savonitto S, Violini R, Arraiz G, Plebani M, Olivari Z, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J. 2005;26(15):1494–8.PubMedCrossRef Cavallini C, Savonitto S, Violini R, Arraiz G, Plebani M, Olivari Z, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J. 2005;26(15):1494–8.PubMedCrossRef

go back to reference Fang J, Alderman MH. Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000. Diabetes. 2006;55(3):768–73.PubMedCrossRef Fang J, Alderman MH. Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000. Diabetes. 2006;55(3):768–73.PubMedCrossRef

go back to reference Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FWA, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe C, Antman EM, TRITON-TIMI 38 Investigators. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial i. Circulation. 2008; 118(16):1626–1636.PubMedCrossRef Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FWA, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe C, Antman EM, TRITON-TIMI 38 Investigators. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial i. Circulation. 2008; 118(16):1626–1636.PubMedCrossRef

go back to reference Selvin E, Marinopoulos S, Berkenblit G, Rami T, FL B, NR P, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421–31.PubMedCrossRef Selvin E, Marinopoulos S, Berkenblit G, Rami T, FL B, NR P, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421–31.PubMedCrossRef

go back to reference Segre CAW, Hueb W, Garcia RMR, Rezende PC, Favarato D, Strunz CMC, et al. Troponin in diabetic patients with and without chronic coronary artery disease. BMC Cardiovasc Disord. 2015;15(1):72.PubMedPubMedCentralCrossRef Segre CAW, Hueb W, Garcia RMR, Rezende PC, Favarato D, Strunz CMC, et al. Troponin in diabetic patients with and without chronic coronary artery disease. BMC Cardiovasc Disord. 2015;15(1):72.PubMedPubMedCentralCrossRef

go back to reference Savonitto S, Morici N, Nozza A, Cosentino F, Perrone Filardi P, Murena E, et al. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes. Diabetes Vasc Dis Res. 2018;15(1):14–23.CrossRef Savonitto S, Morici N, Nozza A, Cosentino F, Perrone Filardi P, Murena E, et al. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes. Diabetes Vasc Dis Res. 2018;15(1):14–23.CrossRef

go back to reference Noguchi K, Sakakibara M, Asakawa N, Tokuda Y, Kamiya K, Yoshitani T, et al. Higher hemoglobin A1c after discharge is an independent predictor of adverse outcomes in patients with acute coronary syndrome– findings from the PACIFIC registry. Circ J. 2016;80(7):1607–14.PubMedCrossRef Noguchi K, Sakakibara M, Asakawa N, Tokuda Y, Kamiya K, Yoshitani T, et al. Higher hemoglobin A1c after discharge is an independent predictor of adverse outcomes in patients with acute coronary syndrome– findings from the PACIFIC registry. Circ J. 2016;80(7):1607–14.PubMedCrossRef

go back to reference Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J. 2011;32(4):404–11.PubMedCrossRef Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J. 2011;32(4):404–11.PubMedCrossRef

go back to reference Dubey TN, Mundada K, Arya A. Correlation of HbA1c with mortality and severity in acute coronary syndrome. Int J Contemp Med Res. 2016;3(8):2244–7. Dubey TN, Mundada K, Arya A. Correlation of HbA1c with mortality and severity in acute coronary syndrome. Int J Contemp Med Res. 2016;3(8):2244–7.

go back to reference Wettersten N, Maisel A. Role of cardiac troponin levels in acute heart failure. Card Fail Rev. 2015;1(2):102–6.PubMedPubMedCentralCrossRef Wettersten N, Maisel A. Role of cardiac troponin levels in acute heart failure. Card Fail Rev. 2015;1(2):102–6.PubMedPubMedCentralCrossRef

go back to reference Gottdiener JS, Arnold M, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, et al. Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2000;35(6):1628–37.PubMedCrossRef Gottdiener JS, Arnold M, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, et al. Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2000;35(6):1628–37.PubMedCrossRef

go back to reference Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27(8):1879–84.PubMedCrossRef Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27(8):1879–84.PubMedCrossRef

go back to reference Gerstein HC, Swedberg K, Carlsson J, McMurray JJV, Michelson EL, Olofsson B, et al. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure. Arch Intern Med. 2008;168(15):1699.PubMedCrossRef Gerstein HC, Swedberg K, Carlsson J, McMurray JJV, Michelson EL, Olofsson B, et al. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure. Arch Intern Med. 2008;168(15):1699.PubMedCrossRef

go back to reference Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. HbA1c and heart failure risk among diabetic patients. J Clin Endocrinol Metab. 2014;99(2):E263–7.PubMedCrossRef Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. HbA1c and heart failure risk among diabetic patients. J Clin Endocrinol Metab. 2014;99(2):E263–7.PubMedCrossRef

go back to reference Aguilar D, Bozkurt B, Ramasubbu K, Deswal A. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol. 2009;54(5):422–8.PubMedPubMedCentralCrossRef Aguilar D, Bozkurt B, Ramasubbu K, Deswal A. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol. 2009;54(5):422–8.PubMedPubMedCentralCrossRef

go back to reference Pazin-Filho A, Kottgen A, Bertoni AG, Russell SD, Selvin E, Rosamond WD, et al. HbA 1c as a risk factor for heart failure in persons with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetologia. 2008;51(12):2197–204.PubMedCrossRef Pazin-Filho A, Kottgen A, Bertoni AG, Russell SD, Selvin E, Rosamond WD, et al. HbA 1c as a risk factor for heart failure in persons with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetologia. 2008;51(12):2197–204.PubMedCrossRef

go back to reference Tomova GS, Nimbal V, Horwich TB. Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus. Am J Cardiol. 2012;109(12):1767–73.PubMedPubMedCentralCrossRef Tomova GS, Nimbal V, Horwich TB. Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus. Am J Cardiol. 2012;109(12):1767–73.PubMedPubMedCentralCrossRef

go back to reference Güder G, Gelbrich G, Edelmann F, Wachter R, Pieske B, Pankuweit S, et al. Reverse epidemiology in different stages of heart failure. Int J Cardiol. 2015;184:216–24.PubMedCrossRef Güder G, Gelbrich G, Edelmann F, Wachter R, Pieske B, Pankuweit S, et al. Reverse epidemiology in different stages of heart failure. Int J Cardiol. 2015;184:216–24.PubMedCrossRef

go back to reference Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. Vol. 43, Journal of the American College of Cardiology. 2004. p. 1439–1444.PubMedCrossRef Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. Vol. 43, Journal of the American College of Cardiology. 2004. p. 1439–1444.PubMedCrossRef

go back to reference Grembowski D, Ralston JD, Anderson ML. Hemoglobin A1c, comorbid conditions and all-cause mortality in older patients with diabetes: a retrospective 9-year cohort study. Diabetes Res Clin Pract. 2014;106(2):373–82.PubMedCrossRef Grembowski D, Ralston JD, Anderson ML. Hemoglobin A1c, comorbid conditions and all-cause mortality in older patients with diabetes: a retrospective 9-year cohort study. Diabetes Res Clin Pract. 2014;106(2):373–82.PubMedCrossRef

go back to reference Palta P, Huang ES, Kalyani RR, Golden SH, Yeh H-C. Hemoglobin A1c and mortality in older adults with and without diabetes: results from the National Health and nutrition examination surveys (1988–2011). Diabetes Care. 2017;40(4):453–60.PubMedPubMedCentralCrossRef Palta P, Huang ES, Kalyani RR, Golden SH, Yeh H-C. Hemoglobin A_1c and mortality in older adults with and without diabetes: results from the National Health and nutrition examination surveys (1988–2011). Diabetes Care. 2017;40(4):453–60.PubMedPubMedCentralCrossRef

go back to reference Li W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. HbA1c and all-cause mortality risk among patients with type 2 diabetes. Int J Cardiol. 2016;202:490–6.PubMedCrossRef Li W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. HbA1c and all-cause mortality risk among patients with type 2 diabetes. Int J Cardiol. 2016;202:490–6.PubMedCrossRef

go back to reference Zhong G-C, Ye M-X, Cheng J-H, Zhao Y, Gong J-P. HbA1c and risks of all-cause and cause-specific death in subjects without known diabetes: a dose-response meta-analysis of prospective cohort studies. Sci Rep. 2016;6:24071.PubMedPubMedCentralCrossRef Zhong G-C, Ye M-X, Cheng J-H, Zhao Y, Gong J-P. HbA1c and risks of all-cause and cause-specific death in subjects without known diabetes: a dose-response meta-analysis of prospective cohort studies. Sci Rep. 2016;6:24071.PubMedPubMedCentralCrossRef

go back to reference Aneja A, Tang WHW, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med. 2008;121(9):748–57.PubMedCrossRef Aneja A, Tang WHW, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med. 2008;121(9):748–57.PubMedCrossRef

go back to reference Bayeva M, Sawicki KT, Ardehali H. Taking diabetes to heart-deregulation of myocardial lipid metabolism in diabetic cardiomyopathy. J Am Heart Assoc. 2013;2(6):e000433.PubMedPubMedCentralCrossRef Bayeva M, Sawicki KT, Ardehali H. Taking diabetes to heart-deregulation of myocardial lipid metabolism in diabetic cardiomyopathy. J Am Heart Assoc. 2013;2(6):e000433.PubMedPubMedCentralCrossRef

go back to reference Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy. J Am Coll Cardiol. 2008;51(2):93–102.PubMedCrossRef Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy. J Am Coll Cardiol. 2008;51(2):93–102.PubMedCrossRef

go back to reference Evers IM, de Valk HW, Visser GHA. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328(7445):915.PubMedPubMedCentralCrossRef Evers IM, de Valk HW, Visser GHA. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328(7445):915.PubMedPubMedCentralCrossRef

go back to reference Abu-Sulaiman RM, Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol. 2004;25(2):137–40.PubMedCrossRef Abu-Sulaiman RM, Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol. 2004;25(2):137–40.PubMedCrossRef

go back to reference Russell NE, Higgins MF, Amaruso M, Foley M, McAuliffe FM. Troponin T and pro-B-type natriuretic peptide in fetuses of type 1 diabetic mothers. Diabetes Care. 2009;32(11):2050–5.PubMedPubMedCentralCrossRef Russell NE, Higgins MF, Amaruso M, Foley M, McAuliffe FM. Troponin T and pro-B-type natriuretic peptide in fetuses of type 1 diabetic mothers. Diabetes Care. 2009;32(11):2050–5.PubMedPubMedCentralCrossRef

go back to reference Rasmussen AL, Lauszus FF. Umbilical pulsatility index is associated with fetalacidemia in type 1 diabetic pregnancies. Gynecol Obstet. 2013;03(03):1–3.CrossRef Rasmussen AL, Lauszus FF. Umbilical pulsatility index is associated with fetalacidemia in type 1 diabetic pregnancies. Gynecol Obstet. 2013;03(03):1–3.CrossRef

go back to reference Lee W-S, Kim J. Diabetic cardiomyopathy: where we are and where we are going. Korean J Intern Med. 2017;32(3):404–21.PubMedPubMedCentralCrossRef Lee W-S, Kim J. Diabetic cardiomyopathy: where we are and where we are going. Korean J Intern Med. 2017;32(3):404–21.PubMedPubMedCentralCrossRef

go back to reference Sandhu R, Aronow WS, Rajdev A, Sukhija R, Amin H, D’aquila K, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol. 2008; ;102: 632–634.PubMedCrossRef Sandhu R, Aronow WS, Rajdev A, Sukhija R, Amin H, D’aquila K, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol. 2008; ;102: 632–634.PubMedCrossRef

go back to reference Fure B, Bruun Wyller T, Thommessen B. Electrocardiographic and troponin T changes in acute ischaemic stroke. J Intern Med. 2006;259(6):592–7.PubMedCrossRef Fure B, Bruun Wyller T, Thommessen B. Electrocardiographic and troponin T changes in acute ischaemic stroke. J Intern Med. 2006;259(6):592–7.PubMedCrossRef

go back to reference Jensen JK, Atar D, Mickley H. Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol. 2007;99(6):867–70.PubMedCrossRef Jensen JK, Atar D, Mickley H. Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol. 2007;99(6):867–70.PubMedCrossRef

go back to reference James P, Ellis CJ, Whitlock RML, McNeil AR, Henley J, Anderson NE. Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. Br Med J. 2000;320(7248):1502–4.CrossRef James P, Ellis CJ, Whitlock RML, McNeil AR, Henley J, Anderson NE. Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. Br Med J. 2000;320(7248):1502–4.CrossRef

go back to reference Dixit S, Castle M, Velu RP, Swisher L, Hodge C, Jaffe AS. Cardiac involvement in patients with acute neurologic disease: confirmation with cardiac troponin I. Arch Intern Med. 2000;160(20):3153–8.PubMedCrossRef Dixit S, Castle M, Velu RP, Swisher L, Hodge C, Jaffe AS. Cardiac involvement in patients with acute neurologic disease: confirmation with cardiac troponin I. Arch Intern Med. 2000;160(20):3153–8.PubMedCrossRef

go back to reference Faiz KW, Thommessen B, Einvik G, Omland T, Rønning OM. Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(2):241–8.PubMedCrossRef Faiz KW, Thommessen B, Einvik G, Omland T, Rønning OM. Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(2):241–8.PubMedCrossRef

go back to reference Fan Y, Jiang M, Gong D, Man C, Chen Y. Cardiac troponin for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis. Biosci Rep. 2018;38(2):BSR20171178.PubMedPubMedCentralCrossRef Fan Y, Jiang M, Gong D, Man C, Chen Y. Cardiac troponin for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis. Biosci Rep. 2018;38(2):BSR20171178.PubMedPubMedCentralCrossRef

go back to reference Budincevic H, Sremec J, Crnac P, Ostojic V, Galic E, Bielen I. Impact of troponin I on outcome of ischemic stroke patients. Rom J Intern Med. 2017;55(1):19–22.PubMed Budincevic H, Sremec J, Crnac P, Ostojic V, Galic E, Bielen I. Impact of troponin I on outcome of ischemic stroke patients. Rom J Intern Med. 2017;55(1):19–22.PubMed

go back to reference Scheitz JF, Nolte CH, Laufs U, Endres M. Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke. Stroke. 2015;46(4):1132–40.PubMedCrossRef Scheitz JF, Nolte CH, Laufs U, Endres M. Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke. Stroke. 2015;46(4):1132–40.PubMedCrossRef

go back to reference Su Y-C, Huang K-F, Yang F-Y, Lin S-K Elevation of troponin I in acute ischemic stroke PeerJ 2016; 4: e1866. Su Y-C, Huang K-F, Yang F-Y, Lin S-K Elevation of troponin I in acute ischemic stroke PeerJ 2016; 4: e1866.

go back to reference Mitsios JP, Ekinci EI, Mitsios GP, Churilov L, Thijs V. Relationship between glycated hemoglobin and stroke risk: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7(11):e007858.PubMedPubMedCentralCrossRef Mitsios JP, Ekinci EI, Mitsios GP, Churilov L, Thijs V. Relationship between glycated hemoglobin and stroke risk: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7(11):e007858.PubMedPubMedCentralCrossRef

go back to reference Hjalmarsson C, Manhem K, Bokemark L, Andersson B. The role of prestroke glycemic control on severity and outcome of acute ischemic stroke. Stroke Res Treat. 2014;2014:694569.PubMedPubMedCentral Hjalmarsson C, Manhem K, Bokemark L, Andersson B. The role of prestroke glycemic control on severity and outcome of acute ischemic stroke. Stroke Res Treat. 2014;2014:694569.PubMedPubMedCentral

go back to reference Sunanda T, Sampath Kumar NS, Amaresh Reddy P, Vallampalli G, PNS P. Role of HbA1c at admission on severity and functional outcome of ischemic stroke in patients with diabetes mellitus. J Neurol Neurophysiol. 2016;7(3):1–7. Sunanda T, Sampath Kumar NS, Amaresh Reddy P, Vallampalli G, PNS P. Role of HbA1c at admission on severity and functional outcome of ischemic stroke in patients with diabetes mellitus. J Neurol Neurophysiol. 2016;7(3):1–7.

go back to reference Shin SB, Kim TU, Hyun JK, Kim JY. The prediction of clinical outcome using HbA1c in acute ischemic stroke of the deep branch of middle cerebral artery. Ann Rehabil Med. 2015;39(6):1011–7.PubMedPubMedCentralCrossRef Shin SB, Kim TU, Hyun JK, Kim JY. The prediction of clinical outcome using HbA1c in acute ischemic stroke of the deep branch of middle cerebral artery. Ann Rehabil Med. 2015;39(6):1011–7.PubMedPubMedCentralCrossRef

go back to reference Jing J, Pan Y, Zhao X, Zheng H, Jia Q, Li H, et al. Prognosis of ischemic stroke with newly diagnosed diabetes mellitus according to hemoglobin A1c criteria in Chinese population. Stroke. 2016;47(8):2038–44.PubMedCrossRef Jing J, Pan Y, Zhao X, Zheng H, Jia Q, Li H, et al. Prognosis of ischemic stroke with newly diagnosed diabetes mellitus according to hemoglobin A1c criteria in Chinese population. Stroke. 2016;47(8):2038–44.PubMedCrossRef

go back to reference Latini R, Masson S, Pirelli S, Barlera S, Pulitano G, Carbonieri E, et al. Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial. J Intern Med. 2011;269(2):160–71.PubMedCrossRef Latini R, Masson S, Pirelli S, Barlera S, Pulitano G, Carbonieri E, et al. Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial. J Intern Med. 2011;269(2):160–71.PubMedCrossRef

go back to reference Ben Yedder N, Roux JF, Paredes FA. Troponin elevation in supraventricular tachycardia: primary dependence on heart rate. Can J Cardiol. 2011;27(1):105–9.PubMedCrossRef Ben Yedder N, Roux JF, Paredes FA. Troponin elevation in supraventricular tachycardia: primary dependence on heart rate. Can J Cardiol. 2011;27(1):105–9.PubMedCrossRef

go back to reference Liu Z, Cui L, Wang Y, Guo Y. Cardiac troponin I and ventricular arrhythmia in patients with chronic heart failure. Eur J Clin Investig. 2006;36(7):466–72.CrossRef Liu Z, Cui L, Wang Y, Guo Y. Cardiac troponin I and ventricular arrhythmia in patients with chronic heart failure. Eur J Clin Investig. 2006;36(7):466–72.CrossRef

go back to reference Agarwal G, Singh SK. Arrhythmias in type 2 diabetes mellitus. Indian J Endocrinol Metab. 2017;21(5):715–8.PubMedPubMedCentralCrossRef Agarwal G, Singh SK. Arrhythmias in type 2 diabetes mellitus. Indian J Endocrinol Metab. 2017;21(5):715–8.PubMedPubMedCentralCrossRef

go back to reference Dafaalla MD, Nimir MN, Mohammed MI, Ali OA, Hussein A. Risk factors of diabetic cardiac autonomic neuropathy in patients with type 1 diabetes mellitus: a meta-analysis. Open Hear. 2016;3(2):e000336.CrossRef Dafaalla MD, Nimir MN, Mohammed MI, Ali OA, Hussein A. Risk factors of diabetic cardiac autonomic neuropathy in patients with type 1 diabetes mellitus: a meta-analysis. Open Hear. 2016;3(2):e000336.CrossRef

go back to reference Christiansen CB, Gerds TA, Olesen JB, Kristensen SL, Lamberts M, Lip GYH, et al. Atrial fibrillation and risk of stroke: a nationwide cohort study. Europace. 2016;18(11):1689–97.PubMedCrossRef Christiansen CB, Gerds TA, Olesen JB, Kristensen SL, Lamberts M, Lip GYH, et al. Atrial fibrillation and risk of stroke: a nationwide cohort study. Europace. 2016;18(11):1689–97.PubMedCrossRef

go back to reference Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol. 2017;24(14):1555–66.PubMedPubMedCentralCrossRef Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol. 2017;24(14):1555–66.PubMedPubMedCentralCrossRef

go back to reference Huisman MV, Barco S, Cannegieter SC, Le Gal G, Konstantinides SV, Reitsma PH, et al. Pulmonary embolism. Nat Rev Dis Prim. 2018;4:18028.PubMedCrossRef Huisman MV, Barco S, Cannegieter SC, Le Gal G, Konstantinides SV, Reitsma PH, et al. Pulmonary embolism. Nat Rev Dis Prim. 2018;4:18028.PubMedCrossRef

go back to reference Movahed M-R, Hashemzadeh M, Jamal MM. The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. Chest. 2005;128(5):3568–71.PubMedCrossRef Movahed M-R, Hashemzadeh M, Jamal MM. The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. Chest. 2005;128(5):3568–71.PubMedCrossRef

go back to reference Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J. 1995;130(6):1276–82.PubMedCrossRef Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J. 1995;130(6):1276–82.PubMedCrossRef

go back to reference Meyer T, Binder L, Hruska N, Luthe H, Buchwald AB. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol. 2000;36(5):1632–6.PubMedCrossRef Meyer T, Binder L, Hruska N, Luthe H, Buchwald AB. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol. 2000;36(5):1632–6.PubMedCrossRef

go back to reference Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm hg or higher. Arch Intern Med. 2005;165(15):1777–81.PubMedCrossRef Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm hg or higher. Arch Intern Med. 2005;165(15):1777–81.PubMedCrossRef

go back to reference Lerstad G, Brodin EE, Enga KF, Jorde R, Schirmer H, Njølstad I, et al. Hyperglycemia, assessed according to HbA 1c, and future risk of venous thromboembolism: the Tromsø study. J Thromb Haemost. 2014;12(3):313–9.PubMedCrossRef Lerstad G, Brodin EE, Enga KF, Jorde R, Schirmer H, Njølstad I, et al. Hyperglycemia, assessed according to HbA _1c, and future risk of venous thromboembolism: the Tromsø study. J Thromb Haemost. 2014;12(3):313–9.PubMedCrossRef

go back to reference Bell EJ, Selvin E, Lutsey PL, Nambi V, Cushman M, Folsom AR. Glycemia (hemoglobin A1c) and incident venous thromboembolism in the atherosclerosis risk in communities cohort study. Vasc Med. 2013;18(5):245–50.PubMedPubMedCentralCrossRef Bell EJ, Selvin E, Lutsey PL, Nambi V, Cushman M, Folsom AR. Glycemia (hemoglobin A1c) and incident venous thromboembolism in the atherosclerosis risk in communities cohort study. Vasc Med. 2013;18(5):245–50.PubMedPubMedCentralCrossRef

go back to reference Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, Hoekstra JB. Hyperglycemia: a prothrombotic factor? J Thromb Haemost. 2010;8(8):1663–9.PubMedCrossRef Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, Hoekstra JB. Hyperglycemia: a prothrombotic factor? J Thromb Haemost. 2010;8(8):1663–9.PubMedCrossRef

go back to reference Wu AHB. Release of cardiac troponin from healthy and damaged myocardium. Front Lab Med. 2017;1(3):144–50.CrossRef Wu AHB. Release of cardiac troponin from healthy and damaged myocardium. Front Lab Med. 2017;1(3):144–50.CrossRef

go back to reference Ostermann M, Ayis S, Tuddenham E, Lo J, Lei K, Smith J, et al. Cardiac troponin release is associated with biomarkers of inflammation and ventricular dilatation during critical illness. Shock. 2017;47(6):702–8.PubMedPubMedCentralCrossRef Ostermann M, Ayis S, Tuddenham E, Lo J, Lei K, Smith J, et al. Cardiac troponin release is associated with biomarkers of inflammation and ventricular dilatation during critical illness. Shock. 2017;47(6):702–8.PubMedPubMedCentralCrossRef

go back to reference Ammann P, Fehr T, Minder E, Günter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27(6):965–9.PubMedCrossRef Ammann P, Fehr T, Minder E, Günter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27(6):965–9.PubMedCrossRef

go back to reference Bessière F, Khenifer S, Dubourg J, Durieu I, Lega J-C. Prognostic value of troponins in sepsis: a meta-analysis. Intensive Care Med. 2013;39(7):1181–9.PubMedCrossRef Bessière F, Khenifer S, Dubourg J, Durieu I, Lega J-C. Prognostic value of troponins in sepsis: a meta-analysis. Intensive Care Med. 2013;39(7):1181–9.PubMedCrossRef

go back to reference Alhamdi Y, Abrams ST, Cheng Z, Jing S, Su D, Liu Z, et al. Circulating histones are major mediators of cardiac injury in patients with sepsis. Crit Care Med. 2015;43(10):2094–103.PubMedCrossRef Alhamdi Y, Abrams ST, Cheng Z, Jing S, Su D, Liu Z, et al. Circulating histones are major mediators of cardiac injury in patients with sepsis. Crit Care Med. 2015;43(10):2094–103.PubMedCrossRef

go back to reference Hunter JD, Doddi M. Sepsis and the heart. Br J Anaesth. 2010;104(1):3–11.PubMedCrossRef Hunter JD, Doddi M. Sepsis and the heart. Br J Anaesth. 2010;104(1):3–11.PubMedCrossRef

go back to reference Frydrych LM, Fattahi F, He K, Ward PA, Delano MJ. Diabetes and sepsis: risk, recurrence, and ruination. Front Endocrinol (Lausanne). 2017;8:271.CrossRef Frydrych LM, Fattahi F, He K, Ward PA, Delano MJ. Diabetes and sepsis: risk, recurrence, and ruination. Front Endocrinol (Lausanne). 2017;8:271.CrossRef

go back to reference Vallabhajosyula S, Sakhuja A, Geske JB, Kumar M, Poterucha JT, Kashyap R, et al. Role of admission troponin-T and serial troponin-T testing in predicting outcomes in severe sepsis and septic shock. J Am Heart Assoc. 2017;6(9):e005930.PubMedPubMedCentralCrossRef Vallabhajosyula S, Sakhuja A, Geske JB, Kumar M, Poterucha JT, Kashyap R, et al. Role of admission troponin-T and serial troponin-T testing in predicting outcomes in severe sepsis and septic shock. J Am Heart Assoc. 2017;6(9):e005930.PubMedPubMedCentralCrossRef

go back to reference Moskowitz A, Omar Y, Chase M, Lokhandwala S, Patel P, Andersen LW, et al. Reasons for death in patients with sepsis and septic shock. J Crit Care. 2017;38:284–8.PubMedCrossRef Moskowitz A, Omar Y, Chase M, Lokhandwala S, Patel P, Andersen LW, et al. Reasons for death in patients with sepsis and septic shock. J Crit Care. 2017;38:284–8.PubMedCrossRef

go back to reference Gornik I, Gornik O, Gašparović V. HbA1c is outcome predictor in diabetic patients with sepsis. Diabetes Res Clin Pract. 2007;77(1):120–5.PubMedCrossRef Gornik I, Gornik O, Gašparović V. HbA1c is outcome predictor in diabetic patients with sepsis. Diabetes Res Clin Pract. 2007;77(1):120–5.PubMedCrossRef

go back to reference Small M, Lowe GD, MacCuish AC, Forbes CD. Thrombin and plasmin activity in diabetes mellitus and their association with glycaemic control. Q J Med. 1987;65(248):1025–31.PubMed Small M, Lowe GD, MacCuish AC, Forbes CD. Thrombin and plasmin activity in diabetes mellitus and their association with glycaemic control. Q J Med. 1987;65(248):1025–31.PubMed

go back to reference Zhao Y, Zhang J, Zhang J, Wu J. Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values. PLoS One. 2011;6(1):e16470.PubMedPubMedCentralCrossRef Zhao Y, Zhang J, Zhang J, Wu J. Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values. PLoS One. 2011;6(1):e16470.PubMedPubMedCentralCrossRef

go back to reference Tripodi A, Branchi A, Chantarangkul V, Clerici M, Merati G, Artoni A, et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis. 2011;31(2):165–72.PubMedCrossRef Tripodi A, Branchi A, Chantarangkul V, Clerici M, Merati G, Artoni A, et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis. 2011;31(2):165–72.PubMedCrossRef

go back to reference Tripodi A. Thrombin generation assay and its application in the clinical laboratory. Clin Chem. 2016;62(5):699–707.PubMedCrossRef Tripodi A. Thrombin generation assay and its application in the clinical laboratory. Clin Chem. 2016;62(5):699–707.PubMedCrossRef

go back to reference Akash MSH, Rehman K, Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2013;114(3):525–31.PubMedCrossRef Akash MSH, Rehman K, Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2013;114(3):525–31.PubMedCrossRef

go back to reference Bulum T, Duvnjak L. Insulin resistance in patients with type 1 diabetes: relationship with metabolic and inflammatory parameters. Acta Clinica Croatica. 2013;52:43–51.PubMed Bulum T, Duvnjak L. Insulin resistance in patients with type 1 diabetes: relationship with metabolic and inflammatory parameters. Acta Clinica Croatica. 2013;52:43–51.PubMed

go back to reference Nikiforov NG, Galstyan KO, Nedosugova LV, Elizova NV, Kolmychkova KI, Ivanova EA. Proinflammatory monocyte polarization in type 2 diabetes mellitus and coronary heart disease. Vessel Plus. 2017;1:192–5. Nikiforov NG, Galstyan KO, Nedosugova LV, Elizova NV, Kolmychkova KI, Ivanova EA. Proinflammatory monocyte polarization in type 2 diabetes mellitus and coronary heart disease. Vessel Plus. 2017;1:192–5.

go back to reference Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20(2):87–103.PubMedPubMedCentralCrossRef Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20(2):87–103.PubMedPubMedCentralCrossRef

go back to reference Lachmandas E, Vrieling F, Wilson LG, Joosten SA, Netea MG, Ottenhoff TH, et al. The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with mycobacterium tuberculosis. PLoS One. 2015;10(2):e0117941.PubMedPubMedCentralCrossRef Lachmandas E, Vrieling F, Wilson LG, Joosten SA, Netea MG, Ottenhoff TH, et al. The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with mycobacterium tuberculosis. PLoS One. 2015;10(2):e0117941.PubMedPubMedCentralCrossRef

go back to reference Devaraj S, Jialal I, Yun J-M, Bremer A. Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism. 2011;60(2):256–9.PubMedCrossRef Devaraj S, Jialal I, Yun J-M, Bremer A. Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism. 2011;60(2):256–9.PubMedCrossRef

go back to reference Choi SH, Kim JH, Lim S, Lim JY, Kim KW, Park KS, et al. Monocyte count as a predictor of cardiovascular mortality in older Korean people. Age Ageing. 2017;46(3):433–8.PubMedCrossRef Choi SH, Kim JH, Lim S, Lim JY, Kim KW, Park KS, et al. Monocyte count as a predictor of cardiovascular mortality in older Korean people. Age Ageing. 2017;46(3):433–8.PubMedCrossRef

go back to reference Villarreal-Molina MT, Antuna-Puente B. Adiponectin: anti-inflammatory and cardioprotective effects. Biochimie. 2012;94(10):2143–9.PubMedCrossRef Villarreal-Molina MT, Antuna-Puente B. Adiponectin: anti-inflammatory and cardioprotective effects. Biochimie. 2012;94(10):2143–9.PubMedCrossRef

go back to reference Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr. 2009;4(1):44–9.PubMedCrossRef Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr. 2009;4(1):44–9.PubMedCrossRef

go back to reference Ekmekci H, Ekmekci OB. The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost. 2006;12(2):163–8.PubMedCrossRef Ekmekci H, Ekmekci OB. The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost. 2006;12(2):163–8.PubMedCrossRef

go back to reference Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes 2004; 27(7): 1680-1687. Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes 2004; 27(7): 1680-1687.

go back to reference Ammal EI, Dhafer El-Yassin H, Kareem Sachit Al-Janabi H. The association between adiponectin, insulin and troponin I in patients with acute myocardial infarction. Journal of Al-Nahrain University. 2012;15(3):15–22.CrossRef Ammal EI, Dhafer El-Yassin H, Kareem Sachit Al-Janabi H. The association between adiponectin, insulin and troponin I in patients with acute myocardial infarction. Journal of Al-Nahrain University. 2012;15(3):15–22.CrossRef

go back to reference Group TAC. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.CrossRef Group TAC. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.CrossRef

go back to reference Prabhu S, Pawade Y, Dhamnaskar R, Karamchandani R. Association of HbA1c with kidney dysfunction in diabetes mellitus and cardiovascular diseases. Vol. 9. People’s Journal of Scientific Research. 2016;9(2):1–6. Prabhu S, Pawade Y, Dhamnaskar R, Karamchandani R. Association of HbA1c with kidney dysfunction in diabetes mellitus and cardiovascular diseases. Vol. 9. People’s Journal of Scientific Research. 2016;9(2):1–6.

go back to reference Goderis G, Van Pottelbergh G, Truyers C, Van Casteren V, De Clercq E, Van Den Broeke C, et al. Long-term evolution of renal function in patients with type 2 diabetes mellitus: a registry-based retrospective cohort study. BMJ Open. 2013;3(12):e004029.PubMedPubMedCentralCrossRef Goderis G, Van Pottelbergh G, Truyers C, Van Casteren V, De Clercq E, Van Den Broeke C, et al. Long-term evolution of renal function in patients with type 2 diabetes mellitus: a registry-based retrospective cohort study. BMJ Open. 2013;3(12):e004029.PubMedPubMedCentralCrossRef

go back to reference Yokoyama H, Kanno S, Takahashi S, Yamada D, Itoh H, Saito K, et al. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or withoutd iabetes and hypertension. Clin J Am Soc Nephrol. 2009;4(9):1432–40.PubMedPubMedCentralCrossRef Yokoyama H, Kanno S, Takahashi S, Yamada D, Itoh H, Saito K, et al. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or withoutd iabetes and hypertension. Clin J Am Soc Nephrol. 2009;4(9):1432–40.PubMedPubMedCentralCrossRef

go back to reference Kuo I-C, Lin HY-H, Niu S-W, Hwang D-Y, Lee J-J, Tsai J-C, et al. Glycated hemoglobin and outcomes in patients with advanced diabetic chronic kidney disease. Sci Rep. 2016;6(1):20028.PubMedPubMedCentralCrossRef Kuo I-C, Lin HY-H, Niu S-W, Hwang D-Y, Lee J-J, Tsai J-C, et al. Glycated hemoglobin and outcomes in patients with advanced diabetic chronic kidney disease. Sci Rep. 2016;6(1):20028.PubMedPubMedCentralCrossRef

go back to reference Oh SW, Kim YC, Koo HS, Jin DC, Na KY, Chae DW, et al. Glycated haemoglobin and the incidence of end-stage renal disease in diabetics. Nephrol Dial Transplant. 2011;26(7):2238–44.PubMedCrossRef Oh SW, Kim YC, Koo HS, Jin DC, Na KY, Chae DW, et al. Glycated haemoglobin and the incidence of end-stage renal disease in diabetics. Nephrol Dial Transplant. 2011;26(7):2238–44.PubMedCrossRef

go back to reference Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, Bello A, James M, Turin TC, Tonelli M, Alberta Kidney Disease Network. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease. Arch Intern Med 2011;171(21):1920, 1927.PubMedCrossRef Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, Bello A, James M, Turin TC, Tonelli M, Alberta Kidney Disease Network. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease. Arch Intern Med 2011;171(21):1920, 1927.PubMedCrossRef

go back to reference Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1121–7.PubMedPubMedCentralCrossRef Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1121–7.PubMedPubMedCentralCrossRef

go back to reference Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial. 2004;17(5):365–70.PubMedCrossRef Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial. 2004;17(5):365–70.PubMedCrossRef

go back to reference Biesenbach G, Raml A, Schmeckle B, Eichbauer-Sturm G. Decreased insulin requirement in relation to GFR in nephropathic type 1 and insulin-treated type 2 diabetic patients. Diabet Med. 2003;20(8):642–5.PubMedCrossRef Biesenbach G, Raml A, Schmeckle B, Eichbauer-Sturm G. Decreased insulin requirement in relation to GFR in nephropathic type 1 and insulin-treated type 2 diabetic patients. Diabet Med. 2003;20(8):642–5.PubMedCrossRef

go back to reference Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007;30(5):1049–55.PubMedCrossRef Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007;30(5):1049–55.PubMedCrossRef

go back to reference Michos ED, Wilson LM, Yeh H-C, Berger Z, Suarez-Cuervo C, Stacy SR, et al. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome. Ann Intern Med. 2014;161(7):491–501.PubMedCrossRef Michos ED, Wilson LM, Yeh H-C, Berger Z, Suarez-Cuervo C, Stacy SR, et al. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome. Ann Intern Med. 2014;161(7):491–501.PubMedCrossRef

go back to reference Pálsson R, Patel UD. Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21(3):273–80.PubMedPubMedCentralCrossRef Pálsson R, Patel UD. Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21(3):273–80.PubMedPubMedCentralCrossRef

go back to reference Astor BC, Hallan SI, Miller ER, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008;167(10):1226–34.PubMedCrossRef Astor BC, Hallan SI, Miller ER, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008;167(10):1226–34.PubMedCrossRef

go back to reference Bello AK, Hemmelgarn B, Lloyd A, James MT, Manns BJ, Klarenbach S, Tonelli M, Alberta Kidney Disease Network. Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clin J Am Soc Nephrol 2011; 6(6):1418–1426.PubMedPubMedCentralCrossRef Bello AK, Hemmelgarn B, Lloyd A, James MT, Manns BJ, Klarenbach S, Tonelli M, Alberta Kidney Disease Network. Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clin J Am Soc Nephrol 2011; 6(6):1418–1426.PubMedPubMedCentralCrossRef

go back to reference Pervan P, Svaguša T, Prkačin I, Vuković J, Radeljak A, Perkov S. Urine concentrations of high-sensitivity cardiac troponin I in healthy adults-preliminary reference intervals. Acta Medica Croat. 2018;72:461–5. Pervan P, Svaguša T, Prkačin I, Vuković J, Radeljak A, Perkov S. Urine concentrations of high-sensitivity cardiac troponin I in healthy adults-preliminary reference intervals. Acta Medica Croat. 2018;72:461–5.

go back to reference Svaguša T, Golub A, Pikivaca T, Savuk A, Perkov S, Jureković Ž, et al. High sensitive troponin concentration stability in dialysate of anuric patients on hemodialysis. Signa Vitae. 2018;14(1):35–8. Svaguša T, Golub A, Pikivaca T, Savuk A, Perkov S, Jureković Ž, et al. High sensitive troponin concentration stability in dialysate of anuric patients on hemodialysis. Signa Vitae. 2018;14(1):35–8.